Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.

We recently published an article titled Why These 10 Dividend Stocks Are Declining? In this article, we are going to take a ...

Guggenheim maintained a Buy rating on Merck (NYSE:MRK) shares but reduced the price target to $115 from $122. The adjustment follows a comprehensive review of the pharmaceutical giant's fourth-quarter ...

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck ...

Robert F. Kennedy Jr.'s nomination for US health secretary advances with crucial Republican support, despite controversy over ...

Wall Street rebounds as tech stocks surge, with the S&P 500 up 0.5% amid easing trade tensions and strong corporate earnings.

Financial giants have made a conspicuous bearish move on Merck & Co. Our analysis of options history for Merck & Co MRK revealed 12 unusual trades. Delving into the details, we found 33% of ...

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives ...

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Jim Cramer recently discussed. In his latest appearance on CNBC's Squawk on the ...

Fiji's minister for health and medical services has declared an HIV outbreak. Dr Ratu Atonio Rabici Lalabalavu announced 1093 new HIV cases from the period of January to September 2024. "This ...